These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1692872)

  • 1. Glycoprotein gB of herpes simplex virus expresses type-common and type-specific antigenic determinants in vivo.
    Dix RD
    J Med Virol; 1990 Mar; 30(3):192-5. PubMed ID: 1692872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
    Dix RD; Pereira L; Baringer JR
    Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G; Kaerner HC; Levine M; Schröder CH; Glorioso JC
    J Virol; 1985 Dec; 56(3):930-7. PubMed ID: 2415719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of purified glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Nishiyama K; Ohtomo N; Mori R
    Arch Virol; 1986; 89(1-4):69-80. PubMed ID: 3013134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection.
    Eis-Hübinger AM; Mohr K; Schneweis KE
    Intervirology; 1991; 32(6):351-60. PubMed ID: 1657825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
    Kohl S; Strynadka NC; Hodges RS; Pereira L
    J Clin Invest; 1990 Jul; 86(1):273-8. PubMed ID: 2164044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.
    Dix RD; Mills J
    J Med Virol; 1985 Sep; 17(1):9-18. PubMed ID: 2995573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Ohtomo N; Hayashi Y; Yamamoto M; Mori R
    Microbiol Immunol; 1985; 29(2):143-9. PubMed ID: 2989659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
    Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
    Mester JC; Glorioso JC; Rouse BT
    J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.
    Balachandran N; Bacchetti S; Rawls WE
    Infect Immun; 1982 Sep; 37(3):1132-7. PubMed ID: 6290390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus.
    Meignier B; Jourdier TM; Norrild B; Pereira L; Roizman B
    J Infect Dis; 1987 May; 155(5):921-30. PubMed ID: 3031174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins.
    Metcalf JF; Chatterjee S; Koga J; Whitley RJ
    Intervirology; 1988; 29(1):39-49. PubMed ID: 2838428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A related epitope is consistently present on glycoprotein C of herpes simplex virus type 1 and 2.
    Eis-Hübinger AM; Kleim JP; Mohr K; Schneweis KE
    Acta Virol; 1991 May; 35(3):276-81. PubMed ID: 1719785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
    Sanchez-Pescador L; Paz P; Navarro D; Pereira L; Kohl S
    J Infect Dis; 1992 Sep; 166(3):623-7. PubMed ID: 1380051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.